OpenPR: single-use market 11% CAGR

- A new market report says single‑use bioprocessing is expanding rapidly, with suppliers doubling down on upstream production and sterile consumables. - The study cites an 11.0% CAGR and upstream bioprocessing growth from $8.1bn in 2022 to $24.8bn by 2027. - That trajectory makes suppliers more likely to defend price and allocation for tubing, filters and sterile connectors. (openpr.com)